This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The General Hospital Corporation, University of California. Active years: 2017.
Company Filing History:
1 out of 3,068 
1 out of 15,977 
Years Active: 2017
Title: The Innovative Contributions of Malcolm Casale
Introduction
Malcolm Casale is a notable inventor based in Mission Viejo, CA. He has made significant contributions to the field of neuroscience through his innovative research and patenting activities. His work primarily focuses on the NRF2/KEAP1/ARE pathway, which has implications for treating various neurodegenerative diseases.
Latest Patents
Malcolm Casale holds a patent for "Small molecule activators of NRF2 pathway." This patent relates to compounds that act as activators of the NRF2/KEAP1/ARE pathway. Specifically, these compounds serve as high-affinity reversible bindings for the NRF2 inhibitor, KEAP1. The activation of the NRF2/KEAP1/ARE pathway can repress the expression of inflammatory markers and reduce levels of TNFa, providing neuroprotective anti-inflammatory effects in the central nervous system. Such compounds are useful in treating diseases including Huntington's disease, Parkinson's disease, Alzheimer's disease, inflammation, and cancer. He has been granted 1 patent for this groundbreaking work.
Career Highlights
Throughout his career, Malcolm has worked with prestigious organizations such as The General Hospital Corporation and the University of California. His research has contributed to advancements in understanding and treating complex neurological conditions. His innovative approach has garnered attention in the scientific community.
Collaborations
Malcolm has collaborated with esteemed colleagues, including Leslie Thompson and Ruben Abagyan. These partnerships have further enriched his research and expanded the impact of his work in the field of neuroscience.
Conclusion
Malcolm Casale's contributions to the field of neuroscience through his patent on NRF2 pathway activators highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in the treatment of neurodegenerative diseases.